M&A Activity • Dec 30, 2024
M&A Activity
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 6234R
Versarien PLC
30 December 2024
30 December 2024
Versarien plc
("Versarien" or the "Company")
Update on Sale of Korean Assets
Further to the Company's announcement on 31 August 2024, Versarien (AIM: VRS), the advanced materials engineering group, provides an update on the sale of its Korean plant and equipment to MCK Tech Co. Ltd ("MCK Tech") for a total consideration of £604,000. Versarien has now received a further £150,000 from MCK Tech leaving a balance outstanding of £92,000 plus accrued interest.
Having considered the business opportunities available to MCK Tech, Versarien has agreed a further extension to on or before 28 February 2025 for MCK Tech to make the final payment of £92,000 plus accrued interest. This debt will incur interest at an annual rate of 10.0% and in the event of default the sale agreement provides for payments already made to Versarien to be retained by the Company, with title to the assets remaining with Versarien.
For further information please contact:
| Versarien Stephen Hodge, Chief Executive Officer Chris Leigh, Chief Financial Officer |
c/o IFC |
| SP Angel Corporate Finance (Nominated Adviser and Broker) Matthew Johnson, Adam Cowl |
+44 (0)20 3470 0470 |
| IFC Advisory Limited (Financial PR and Investor Relations) Tim Metcalfe, Zach Cohen |
+44 (0) 20 3934 6630 |
About Versarien:
The strategy of Versarien plc (AIM:VRS) is to be a development led advanced materials company focussed on specific sectors that will lead to a manufacturing-light and licensing model.
For further information please see: http://www.versarien.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
UPDFLFELFDLIVIS
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.